Anakinra usage in febrile infection related epilepsy syndrome: an international cohort

Functional deficiency in endogenous interleukin-1 receptor antagonist in patients with febrile infection-related epilepsy syndrome

(2019) Benjamin D. S. Clarkson et al.   ANNALS OF NEUROLOGY

Centromedian thalamic nuclei deep brain stimulation and Anakinra treatment for FIRES – Two different outcomes

(2019) Mario Sa et al.   EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY

Anakinra in children and adults with Still’s disease

(2019) Sebastiaan J Vastert et al.   RHEUMATOLOGY

New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): State of the art and perspectives

(2018) Nicolas Gaspard et al.   EPILEPSIA

Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions

(2018) Lawrence J. Hirsch et al.   EPILEPSIA

Plasma cytokines associated with febrile status epilepticus in children: A potential biomarker for acute hippocampal injury

(2017) William B. Gallentine et al.   EPILEPSIA

Febrile infection-related epilepsy syndrome treated with anakinra

(2016) Daniel L. Kenney-Jung et al.   ANNALS OF NEUROLOGY

Infiltrating monocytes promote brain inflammation and exacerbate neuronal damage after status epilepticus

(2016) Nicholas H. Varvel et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey

(2015) Linda Rossi-Semerano et al.   Orphanet Journal of Rare Diseases

Febrile infection-related epilepsy syndrome (FIRES): Pathogenesis, treatment, and outcome

(2011) Uri Kramer et al.   EPILEPSIA

Febrile infection-related epilepsy syndrome (FIRES): A nonencephalitic encephalopathy in childhood

(2010) Andreas Van Baalen et al.   EPILEPSIA